Showing results (51-60 of 197) with videos related to

Sort By:
Pageof 20
Immunologic Research|August 19, 2007
Human gamma delta T cells: candidates for the development of immunotherapeutic strategiesSusann Beetz, Lothar Marischen, Dieter Kabelitz, et al.
Cancer Immunology, Immunotherapy : CII|January 25, 2008
Anti-angiogenic active immunotherapy: a new approach to cancer treatmentJianping Pan, Pengfeng Jin, Jie Yan, et al.
Current Medicinal Chemistry|August 5, 2008
Storage, expression and function of Fas ligand, the key death factor of immune cellsMarcus Lettau, Maren Paulsen, Dieter Kabelitz, et al.
Immunotherapy|July 20, 2010
gammadelta T cells in cancer immunotherapy: current status and future prospectsShubhada Chiplunkar, Swati Dhar, Daniela Wesch, et al.
Molecular Immunology|March 10, 2015
Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytesHenriette Ebsen, Marcus Lettau, Dieter Kabelitz, et al.
Frontiers in Immunology|August 6, 2019
Regulatory Interactions Between Neutrophils, Tumor Cells and T CellsHans-Heinrich Oberg, Daniela Wesch, Shirin Kalyan, et al.
Cellular and Molecular Life Sciences : CMLS|October 5, 2013
Phenotype and regulation of immunosuppressive Vδ2-expressing γδ T cellsChristian Peters, Hans-Heinrich Oberg, Dieter Kabelitz, et al.
Immunologic Research|October 20, 2005
Death receptors and caspases: role in lymphocyte proliferation, cell death, and autoimmunitySabine Adam-Klages, Dieter Adam, Ottmar Janssen, et al.
Trends in Immunology|July 16, 2017
The Ambiguous Role of γδ T Lymphocytes in Antitumor ImmunityGuranda Chitadze, Hans-Heinrich Oberg, Daniela Wesch, et al.
Methods in Enzymology|January 18, 2020
Real-time cell analysis (RTCA) to measure killer cell activity against adherent tumor cells in vitroHans-Heinrich Oberg, Christian Peters, Dieter Kabelitz, et al.
Pageof 20